Literature DB >> 6834069

High levels of brain dolichols in neuronal ceroid-lipofuscinosis and senescence.

N M Ng Ying Kin, J Palo, M Haltia, L S Wolfe.   

Abstract

Dolichols as unesterified alcohols were identified as significant components of lipid extracts from storage cytosomes isolated post-mortem from the brains of patients with the infantile, late infantile, and juvenile types of neuronal ceroid-lipofuscinosis (NCL). Very small amounts of dolichols were present in the corresponding subcellular fractions of non-NCL brains. The nuclear fraction from NCL cerebral cortex contained the highest dolichol content expressed per milligram protein or lipid, whereas the crude mitochondrial fraction was the richest in normal brain. Highly significant elevations of dolichol levels were found in human cerebral cortex of patients with NCL and Alzheimer's disease compared with age-matched controls, but the levels were normal in Pick's disease. In human non-NCL cerebral cortex, dolichols increased from 16 micrograms/g at age 5 to over 200 at age 81. Rat cerebral cortex showed a similar progressive increase in dolichol content with age. The high dolichol values in NCL, Alzheimer's disease, and senescence appears to be related to the increase of lipofuscin in brain. This is the first time a uniform biochemical abnormality has been found in all childhood forms of NCL, but the enzyme defect is still unidentified. It may lie on pathways where dolichols and retinyl compounds are recycled in Golgi membranes and derived organelles during the biosynthesis of glycoproteins.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6834069     DOI: 10.1111/j.1471-4159.1983.tb13592.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  18 in total

1.  Building a cathedral: neuroscience and the legacy of Leon Wolfe.

Authors:  Matthew W Spence
Journal:  Mol Neurobiol       Date:  2005-08       Impact factor: 5.590

Review 2.  Statins and neuroprotection: basic pharmacology needed.

Authors:  W Gibson Wood; Walter E Mΰller; Gunter P Eckert
Journal:  Mol Neurobiol       Date:  2014-01-29       Impact factor: 5.590

Review 3.  Isoprenoids, small GTPases and Alzheimer's disease.

Authors:  Gero P Hooff; W Gibson Wood; Walter E Müller; Gunter P Eckert
Journal:  Biochim Biophys Acta       Date:  2010-04-08

Review 4.  The biological role of dolichol.

Authors:  T Chojnacki; G Dallner
Journal:  Biochem J       Date:  1988-04-01       Impact factor: 3.857

5.  A micromethod for the estimation of blood dolichol.

Authors:  G N Morris; R K Pullarkat
Journal:  Lipids       Date:  1987-01       Impact factor: 1.880

6.  Lectin histochemistry in brains with juvenile form of neuronal ceroid-lipofuscinosis (Batten disease).

Authors:  K E Wisniewski; D Maslinska
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

7.  Dolichol metabolism in cultured skin fibroblasts from patients with "neuronal" ceroid lipofuscinosis (Batten's disease).

Authors:  B C Paton; A Poulos
Journal:  J Inherit Metab Dis       Date:  1984       Impact factor: 4.982

8.  Low-density lipoprotein as a transporter of dolichol intermediates in the mammalian circulation.

Authors:  J W Rip; M M Blais; L W Jiang
Journal:  Biochem J       Date:  1994-01-15       Impact factor: 3.857

9.  Neuromelanin organelles are specialized autolysosomes that accumulate undegraded proteins and lipids in aging human brain and are likely involved in Parkinson's disease.

Authors:  Fabio A Zucca; Renzo Vanna; Francesca A Cupaioli; Chiara Bellei; Antonella De Palma; Dario Di Silvestre; Pierluigi Mauri; Sara Grassi; Alessandro Prinetti; Luigi Casella; David Sulzer; Luigi Zecca
Journal:  NPJ Parkinsons Dis       Date:  2018-06-05

10.  Transfer of liposomes containing dolichol into isolated hepatocytes.

Authors:  O Tollbom; T Chojnacki; G Dallner
Journal:  Lipids       Date:  1992-04       Impact factor: 1.880

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.